Top Markets
#1 Pleasing Gold Pleasing Gold +1,502.41%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.03%
#4 BOOK OF MEME BOOK OF MEME +27.49%
#5 Ontology Gas Ontology Gas +27.07%
#6 Unit Pump Unit Pump +23.05%
#7 Pump.fun Pump.fun +23.05%
#8 Nockchain Nockchain +22.70%
#9 Neiro Neiro +22.35%
#10 ConstitutionDAO ConstitutionDAO +21.16%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NeoCore Technology Co., Ltd. NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd.

4131
Classement en actions #26461
NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture,... NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture, and distribution of biochips and advanced rapid nucleic acid hybridization devices. Their extensive product range features systems designed for food safety screening, human diagnostic arrays, agricultural analysis, and specific food examination arrays, in addition to a variety of laboratory instruments and DNA kits. The company further provides a suite of services, encompassing laboratory planning, design, and additional specialized support. Beyond its core biotech operations, NeoCore also participates in the wholesale and retail market for contact lenses. The firm, which was established in 1987 and is based in Tainan, Taiwan, underwent a name change in July 2023, transitioning from its former identity as DR. Chip Biotechnology Incorporation to its current name.
Prix de l'action
$1.02
Capitalisation boursière
$40.42M
Changement (1 jour)
-1.08%
Changement (1 an)
-10.53%
Pays
TW
Échange NeoCore Technology Co., Ltd. (4131)

Catégorie

Healthcare
Bénéfices pour NeoCore Technology Co., Ltd. (4131)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de NeoCore Technology Co., Ltd., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour NeoCore Technology Co., Ltd. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH